Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories. Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer...
Bora Pharmaceuticals’ $210 Million Acquisition of Upsher-Smith Laboratories
Daiichi Sankyo and Merck’s Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs
Gibson, Dunn & Crutcher LLP is advising Merck on the agreement. Daiichi Sankyo (TSE: 4568) and Merck (known as MSD outside of the United States and...
Patterson-UTI’s $370 Million Acquisition of Ulterra
Gibson, Dunn & Crutcher LLP is advising Patterson-UTI Energy, Inc., while Kirkland & Ellis is advising Blackstone Energy Partners in the transaction. Patterson-UTI Energy, Inc. (NASDAQ:PTEN)...
NexTier’s $5.4 Billion Merger of Equals With Patterson-UTI
Kirkland & Ellis LLP is serving as legal advisor to NexTier, while Gibson, Dunn & Crutcher LLP is serving as legal advisor to Patterson-UTI. Patterson-UTI Energy,...